Panel Discussion: The Impact of Modeling in Drug Development

Authors: Padron A, Siler SQ, Miller N, Suarez-Sharp S, Chauvin J, Owen JS
Conference: SLP MIDD+
Keywords: main stage, MIDD (model-informed drug development), PBPK, PKPD modeling, pop PK model, QSP modeling, SLP2021MIDD
Division: PBPK

We Stand on the Shoulders of Those Who Came Before Us

  • There is a rich, long-standing history of science and mathematical modeling that set the table for the current, rich MIDD environment
  • Technical advances have allowed PBPK, PopPK, PK-PD, QSP and other modeling disciplines to grow considerably over the years
  • The development of software to facilitate the practice of developing and using models has proven to be a catalyst in adoption of modeling within drug development
  • The establishment of academic programs to train students in modeling principles and practice have contributed to the ascent of MIDD

By Arlene Padron, Scott Q Siler, Neil Miller, Sandra Suarez-Sharp, Jonathan Chauvin, Joel Owen

Download Slides

Presented at SLP MIDD+ Virtual Conference March 3-4, 2021